4/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: November 1, 2012
Period of Report: September 26, 2012
Accession Number: 0001437749-12-010836

View Document ↗ View on SEC.gov ↗